4.4 Article

Subsegmental resection preserves regional pulmonary function: A focus on thoracoscopy

期刊

THORACIC CANCER
卷 12, 期 7, 页码 1033-1040

出版社

WILEY
DOI: 10.1111/1759-7714.13841

关键词

forced expiratory volume; left upper lobe; lobectomy; segmentectomy; thoracoscopic surgery

向作者/读者索取更多资源

Segmentectomy is shown to be feasible for preserving postoperative pulmonary function, even with the removal of 5-7 subsegments. Chronic inflammation was identified as a risk factor for preserved pulmonary function postoperatively.
Background The aim of this study was to evaluate regional postoperative preserved pulmonary function (PPPF) and three-dimensional (3D) volumetric changes according to the number of resected subsegments and investigate the factors that most affected pre-/post PPPF. Methods Patients who underwent thoracoscopic lobectomy (n = 73), and segmentectomy (n = 87) were eligible for inclusion in the study. They were classified according to the number of resected subsegments which ranged from 1 to 10. The percentage of pre-/postoperative forced expiratory volume in 1 s (FEV1) was used for comparison. Furthermore, lung volumetric changes were calculated using 3D computed tomography (CT) volumetry. Results The percentage of pre-/postoperative EFV1 between 4 and 5-7 and between 5-7 and 10 were significant (p = 0.03 and p < 0.01, respectively), but not between 1-2 to 4 (p = 0.99). The difference between volumetric changes in the left lower lobe of patients with a number of resected subsegments was significant (p < 0.01). On univariate and multivariate analyses, chronic inflammation was significant for decrease in recovery percentages. When the PPPF was compared among resected subsegments, it gradually decreased with an increase in the number of patients without a postoperative procrastination of inflammation (p < 0.01). Conclusions Segmentectomy is feasible and useful for PPPF. Even a relatively large-volume resection procedure where 5-7 subsegments are resected can preserve pulmonary function. Chronic inflammation was statistically identified as a risk factor for postoperative preserved pulmonary function. Key points

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cardiac & Cardiovascular Systems

Robotic open-thoracotomy-view approach using vertical port placement and confronting monitor setting

Noriaki Sakakura, Takeo Nakada, Suguru Shirai, Hirotomo Takahara, Keita Nakanishi, Takuya Matsui, Harushi Ueno, Yusuke Takahashi, Hiroaki Kuroda

Summary: The robotic 'open-thoracotomy-view approach' with vertical port placement and upside-down monitor setting for robotic lung resections showed successful outcomes, with safe procedures, short duration of surgery and postoperative hospital stay.

INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY (2021)

Article Oncology

Novel strategy to treat lung metastases: Hybrid therapy involving surgery and radiofrequency ablation

Takaaki Hasegawa, Hiroaki Kuroda, Noriaki Sakakura, Yozo Sato, Shohei Chatani, Shinichi Murata, Hidekazu Yamaura, Takeo Nakada, Yuko Oya, Yoshitaka Inaba

Summary: The hybrid treatment involving surgery and radiofrequency ablation showed promising outcomes for patients with multiple lung metastases. However, complications such as empyema, pneumothorax, and lung abscess were observed. During follow-up, 59% of patients developed new metastases, with a 5-year disease-free survival rate of 32%. Factors such as having four or fewer lung metastases and metastases from colorectal carcinoma significantly influenced disease-free survival.

THORACIC CANCER (2021)

Article Oncology

Clinical Guideline-Guided Outcome Consistency for Surgically Resected Stage III Non-Small Cell Lung Cancer: A Retrospective Study

Hiroaki Kuroda, Yusuke Sugita, Katsuhiro Masago, Yusuke Takahashi, Takeo Nakada, Eiichi Sasaki, Noriaki Sakakura, Rui Yamaguchi, Hirokazu Matsushita, Toyoaki Hida

Summary: Evidence-based guidelines are valuable in improving patient treatment and outcomes by reducing clinical variability. Personalized treatments based on genomic and immune profiles show potential benefits in prognosis. Guideline-consistent treatment options in pathological stage III NSCLC significantly improve 5-year survival rates, indicating the importance of adherence to guidelines in clinical practice.

CANCERS (2021)

Article Orthopedics

Intraoperative Multimodal Approach for Pain After Thoracoscopic Pulmonary Resection

Takeo Nakada, Aiko Nakai, Yusuke Takahashi, Noriaki Sakakura, Takashi Ohtsuka, Hiroaki Kuroda

Summary: The study found that the combined use of intravenous analgesics and intercostal nerve blocks during thoracoscopic lobectomy can reduce postoperative pain without complications.

ASIAN JOURNAL OF ENDOSCOPIC SURGERY (2022)

Article Cardiac & Cardiovascular Systems

Effect of resected lung lobe on the prediction of postoperative pulmonary function

Takamasa Shibazaki, Shohei Mori, Yuki Noda, Yo Tsukamoto, Daiki Kato, Takeo Nakada, Mitsuo Yabe, Hideki Matsudaira, Jun Hirano, Takashi Ohtsuka

Summary: Resected lung lobe can affect the accuracy of the subsegment counting method, but not that of 3D-CT volumetry in predicting postoperative FEV1. Furthermore, 3D-CT volumetry can predict postoperative FEV1 independent of the resected lobe.

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2022)

Article Oncology

Esophagobronchial fistula successfully managed with a self-expandable metallic stent followed by fixation using a silicon Y stent

Takashi Ohtsuka, Daiki Kato, Yo Tsukamoto, Takamasa Shibazaki, Takeo Nakada, Mitsuo Yabe, Jun Hirano

Summary: Esophagobronchial fistula formation is a severe complication of advanced thoracic malignancies. This case report describes the treatment of an 80-year-old man with advanced esophageal cancer complicated by EBF formation, who underwent placement of a partially covered SEMS and a silicone Y stent to stabilize the condition, leading to a stable postoperative course.

THORACIC CANCER (2022)

Article Health Care Sciences & Services

Three-Arm Robotic Lung Resection via the Open-Thoracotomy-View Approach Using Vertical Port Placement and Confronting Monitor Setting: Focusing on Segmentectomy

Noriaki Sakakura, Takeo Nakada, Yusuke Takahashi, Ayumi Suzuki, Shuichi Shinohara, Hiroaki Kuroda

Summary: The three-arm robotic open thoracotomy-view (OTVA) approach provides natural thoracotomy views and can be an alternative for segmentectomy and lobectomy. The use of a fluorescence imaging system allows for clear visualization of cranial-side intrathoracic structures that are often hidden in the conventional look-up-view method. The console operation time is significantly shorter for segmentectomy, and more staplers are used compared to lobectomy.

JOURNAL OF PERSONALIZED MEDICINE (2022)

Article Surgery

Comparative study of local versus general anesthesia in video-assisted thoracoscopic surgery for empyema

Yo Tsukamoto, Makoto Odaka, Takeo Nakada, Mitsuo Yabe, Eriko Harada, Tadashi Akiba, Naoki Toya, Takashi Ohtsuka

Summary: This study evaluated the feasibility of non-intubated video-assisted thoracoscopic surgery with local anesthesia for parapneumonic effusion and empyema resistant to conservative treatment. The study found some differences between patients who received local anesthesia and general anesthesia during surgery, but there were no significant differences in postoperative drainage duration, postoperative complication rate, and postoperative 30-day mortality rate.

ASIAN JOURNAL OF SURGERY (2023)

Review Health Care Sciences & Services

Port Placement Variations for Robotic Lung Resection: Focusing on Their History, Conventional Look-Up-View and Horizontal Open-Thoracotomy-View Techniques, and More

Noriaki Sakakura, Takashi Eguchi

Summary: This narrative review summarizes the variations in approaches and port placements used for robotic lung resections. The four-arm, look-up-view method is considered the mainstream approach worldwide. Several variations have been devised, including horizontal open-thoracotomy-view techniques and fewer port and incision techniques. Familiarity with these variations allows thoracic surgeons to choose the optimal procedure for each patient.

JOURNAL OF PERSONALIZED MEDICINE (2023)

Article Cardiac & Cardiovascular Systems

Postoperative surveillance using low-dose computed tomography for non-small-cell lung cancer

Takeo Nakada, Yusuke Takahashi, Noriaki Sakakura, Katsuhiro Masago, Hiroshi Iwata, Takashi Ohtsuka, Hiroaki Kuroda

Summary: After using propensity score matched, there was no significant difference in recurrence-free survival (RFS) and overall survival (OS) between the LDCT and conventional CT groups for pathological stage I non-small-cell lung cancer (NSCLC) patients. Retrospective comparisons suggest no disadvantages of using LDCT for postoperative surveillance.

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2022)

Article Cardiac & Cardiovascular Systems

Analysis of postoperative weight loss associated with prognosis after lobectomy for lung cancer

Takeo Nakada, Yo Tsukamoto, Daiki Kato, Takamasa Shibazaki, Mitsuo Yabe, Jun Hirano, Takashi Ohtsuka

Summary: This study investigated the association between weight loss after lung cancer surgery and short-mid-term prognosis. The results showed that weight loss from 6 to 12 months after surgery was associated with poor prognosis. Ongoing nutritional management is important to prevent life-threatening weight loss in patients with predictive factors.

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2022)

Article Oncology

Prognostic Radiological Tools for Clinical Stage IA Pure Solid Lung Cancer

Takeo Nakada, Yusuke Takahashi, Noriaki Sakakura, Hiroshi Iwata, Takashi Ohtsuka, Hiroaki Kuroda

Summary: This study found that prognostic radiological tools and surgical outcomes for radiologically pure solid adenocarcinomas and squamous cell carcinoma in clinical stage IA were similar. SUVmax was useful in predicting recurrence, while tumor diameter and SUVmax were helpful in predicting pathological lymph node metastasis.

CURRENT ONCOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Selection of Pathological N0 (pN0) in Clinical IA (cIA) Lung Adenocarcinoma by Imaging Findings of the Main Tumor

Yasuyuki Kanamoto, Yukinori Sakao, Hiroaki Kuroda, Noriaki Sakakura, Momoko Asami, Yuichi Saito, Masafumi Kawamura

Summary: The study found that MD, CD, and C/T are significant factors related to lymph node metastasis, with potential predictive value. For patients with cIA lung adenocarcinoma and normal CEA levels, MD, CD, and C/T may be reliable indicators for omitting lymph node dissection.

ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY (2021)

Article Oncology

IgG4-related retroperitoneal fibrosis induced by nivolumab and ipilimumab in a patient with non-small cell lung cancer: A case report

Masashi Nishimura, Yoshifumi Kimizuka, Takunori Ogawa, Motohiro Tsuchiya, Yoshiki Kato, Akira Matsukida, Shunya Igarashi, Koki Ito, Yusuke Serizawa, Tomomi Tanigaki, Yuji Fujikura, Yuka Katsurada, Sho Ogata, Akihiko Kawana

Summary: This study reports a case of IgG4-related retroperitoneal fibrosis occurring after chemotherapy. The patient showed improvement after discontinuing immunotherapy and receiving steroid treatment.

THORACIC CANCER (2024)

Article Oncology

Different effects of crizotinib treatment in two non-small cell lung cancer patients with SDC4::ROS1 fusion variants

Yuta Ohishi, Yoko Nakanishi, Yukari Hirotani, Atsuko Suzuki, Tomoyuki Tanino, Haruna Nishimaki-Watanabe, Hiroko Kobayashi, Fumi Nozaki, Sumie Ohni, Xiaoyan Tang, Kentaro Hayashi, Yoshiko Nakagawa, Tetsuo Shimizu, Ichiro Tsujino, Noriaki Takahashi, Yasuhiro Gon, Shinobu Masuda

Summary: This study aimed to investigate the clinicopathological differences and therapeutic response of NSCLC patients with SDC4::ROS1 fusion to crizotinib. The study found that different ROS1 fusion partners may affect the efficacy of crizotinib and patient prognosis. In addition, higher expression levels of ROS1 and pERK1/2 in tumor cells of case 2 may be related to the therapeutic response and prognosis.

THORACIC CANCER (2024)

Review Oncology

Advances in new targets for immunotherapy of small cell lung cancer

Zitong Zheng, Juanjuan Liu, Junling Ma, Runting Kang, Zhen Liu, Jiangyong Yu

Summary: Small cell lung cancer (SCLC) is a highly aggressive malignancy with limited treatment options. Over the past decade, immunotherapy has made progress in the treatment of SCLC, but current immune checkpoint inhibitors have limited benefits for patient survival. Therefore, it is important to explore new targets and develop drugs with novel mechanisms for immunotherapy in SCLC.

THORACIC CANCER (2024)

Article Oncology

A case of a shrunken multilocular mediastinal cyst that developed into thymic carcinoma with lung metastases 13 years later

Kazuto Sugai, Kojiro Nakaoka, Rika Tobita, Shinji Kikuchi, Kei Inoue, Midori Enokido, Moriyuki Kiyoshima

Summary: This article presents a case of multilocular mediastinal cyst leading to the development of thymic cancer. Resection of multilocular anterior mediastinal cysts should be considered due to the challenges in preoperative diagnosis, the potential for coexisting tumors with cysts, and the risk of malignant tumor development.

THORACIC CANCER (2024)